![Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times](https://static01.nyt.com/images/2019/05/11/business/11xp-teva2/11xp-teva2-superJumbo.jpg)
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today](https://today.uic.edu/wp-content/uploads/2022/02/medicine-6902841_1920-590x393.jpg)
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today
![Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" / Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /](https://pbs.twimg.com/media/EvVCGYZXIAU0Cfw.jpg)
Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/819865/4/TEVA_DH-AirDuo_Inhaler_PhoneL_Conv_LU_W_noBG.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510361134502628576/filePointer/510361134502769765/fodoid/510361134502769762/imageType/LARGE/inlineImage/true/QVAR.jpg)
Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/LARGE/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)